Jeffrey Humphrey's Net Worth
$176 Thousand
Who is Jeffrey Humphrey?
Jeffrey Humphrey does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Magenta Therapeutics, Inc., Cyteir Therapeutics, Inc., and Lantheus Holdings, Inc..
SEC CIK
Jeffrey Humphrey's CIK is 0001816944
Past Insider Trading and Trends
2022 was Jeffrey Humphrey's most active year for acquiring shares with 4 total transactions. Jeffrey Humphrey's most active month to acquire stocks was the month of January. 2021 was Jeffrey Humphrey's most active year for disposing of shares, totalling 2 transactions. Jeffrey Humphrey's most active month to dispose stocks was the month of June. 2024 saw Jeffrey Humphrey paying a total of $749,949.88 for 25,264 shares, this is the most they've acquired in one year. In 2021 Jeffrey Humphrey cashed out on 168,055 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONSTELLATION PHARMACEUTICALS INC No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Magenta Therapeutics, Inc. (DNTH) Snapshot price: $26.62
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cyteir Therapeutics, Inc. (CYT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lantheus Holdings, Inc. (LNTH) Snapshot price: $101.98
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 9.08K |
$82.63 | $749,949.88 | 9.08K |
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||